Summary

The global Cold Plasma market is projected to reach USD 3.66 billion by 2029 from USD 2.17 billion in 2024, at a CAGR of 11.0% during the forecast period. The rapid growth and adoption of cold plasma across various industries such as medical, food, electronics etc. catering to wider applications with improved benefits, growing focus on sustaibility, rise in the geriatric population globally and the significant rise in the patients with chronic wound conditions and cancer are expected to boost the demand for cold plasma market. Moreover, gradual rise in utilization of cold plasma due to improved awareness and benefits among various industries is likely to support the market growth. Advancements in cold plasma technology, new product launches, investments in R&D, and initiatives to enhance the accessibility and awareness of cold plasma is anticipated to fuel the market growth.

“The polymer & plastic industry segment of cold plasma market to register highest share during the forecast period.”

Based on the cold plasma market, the polymer & plastic industry cold plasma segment is anticipated to capture highest share during forecast period. The cold plasma market is experiencing growth in the plastic and polymer industry due to its ability to enhance surface properties like adhesion, wettability, and barrier resistance. This technology supports applications in coatings and packaging while offering a non-thermal, eco-friendly alternative that minimizes the use of harsh chemicals. As industries increasingly prioritize product performance and sustainability, alongside a focus on innovation and customization, the adoption of cold plasma technology is expected to accelerate in polymer & plastic industry.





“The surface treatment & activation segment of application segment to capture the largest market share of cold plasma market.”

Based on application, the surface treatment & activation segment registered the highest share and expected to grow at higher pace during forecast period. This can be attributed due to its effectiveness in enhancing adhesion and wettability. Its non-thermal, eco-friendly approach appeals to various industries, driving increased adoption and innovation in applications are boosting the adoption of cold plasma technology in this application.Moreover, advancements in cold plasma technology are enabling more efficient and customizable applications, further propelling its adoption.



“North America accounted for the largest share of the cold plasma market by region.”
The global cold plasma market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is the largest regional market for cold plasma , whereas the Asia Pacific market is estimated to grow at the highest CAGR during the forecast period.
The largest share of North America is attributed to the high disease burden of chronic wound cases and cancer burden disease contributing to a larger pool of patients requiring cold plasma products. The presence of numerous potential market giants and omproved awareness in the region is likely to promote the growth of cold plasma market in North America.


A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1–35%, Tier 2–40%, and Tier 3– 25%
• By Designation: Directors–25%, Managers–50% and Others–25%
• By Region: North America–35%, Europe–30%, Asia Pacific–15% and RoW–20%

The major players operating in the cold plasma market market are Apyx Medical (US), Nordson Corporation (US), Adtec Plasma Technology Co. Ltd. (Japan), P2i Ltd.(UK), Relyon Plasma GmbH (Germany), Henniker Plasma (UK), Enercon Industries Corporation (US), AcXys Plasma Technologies (France), Plasmatreat GmbH (Germany), Tantec A/S (Denmark), Europlasma NV (Belgium), Thierry Corp. (Germany), Surfx Technologies, LLC (US), SOFTAL Corona & Plasma GmbH (Germany), Coating Plasma Innovation (France), Ferrarini & Benelli (Italy), Neoplas GmbH (Germany), Terraplasma GmbH (Germany), Molecular Plasma Group SA (Germany), and CINOGY Technologies GmbH (Germany)

Research Coverage

This report studies the cold plasma market based on industry, application, regime and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).

Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:
 Analysis of Key divers (increased benefits and wider application, rising use in wound healing , growing applications in cancer and infectious disease, technological advancements), restraints (high capital investments), Opportunities (emerging markets, growing sustainability across industries) , Challenge (limited commercialization and awareness, limited key players presence in emerging economies)
 Market Penetration: Comprehensive information on the product portfolios offered by the top players in the cold plasma market
 Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the cold plasma market
 Market Development: Comprehensive information on lucrative emerging regions
 Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the cold plasma market
 Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

ページTOPに戻る

Table of Contents

1 INTRODUCTION 21
1.1 STUDY OBJECTIVES 21
1.2 MARKET DEFINITION 21
1.3 STUDY SCOPE 22
1.3.1 MARKETS COVERED & REGIONAL SCOPE 22
1.3.2 INCLUSIONS & EXCLUSIONS 23
1.3.3 YEARS CONSIDERED 23
1.4 CURRENCY CONSIDERED 23
1.5 STAKEHOLDERS 24
1.6 SUMMARY OF CHANGES 24
2 RESEARCH METHODOLOGY 25
2.1 RESEARCH DATA 25
2.1.1 SECONDARY DATA 26
2.1.1.1 Key data from secondary sources 27
2.1.2 PRIMARY DATA 28
2.1.2.1 Key data from primary sources 29
2.1.2.2 Breakdown of primary sources 31
2.2 MARKET SIZE ESTIMATION 32
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 37
2.4 MARKET RANKING ANALYSIS 38
2.5 STUDY ASSUMPTIONS 38
2.6 RISK ASSESSMENT 38
2.7 LIMITATIONS 39
2.7.1 METHODOLOGY-RELATED LIMITATIONS 39
3 EXECUTIVE SUMMARY 40
4 PREMIUM INSIGHTS 43
4.1 COLD PLASMA MARKET OVERVIEW 43
4.2 ASIA PACIFIC: COLD PLASMA MARKET, BY INDUSTRY 44
4.3 COLD PLASMA MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 45
5 MARKET OVERVIEW 46
5.1 INTRODUCTION 46
5.2 MARKET DYNAMICS 46
5.2.1 DRIVERS 47
5.2.1.1 Increased benefits and wider industrial applications 47
5.2.1.2 Increasing use in wound healing 47
5.2.1.3 Growing applications in cancer and infectious disease treatment 48
5.2.1.4 Technological advancements and new product launches 48
5.2.2 RESTRAINTS 49
5.2.2.1 High capital investments 49
5.2.3 OPPORTUNITIES 50
5.2.3.1 Growing focus on sustainability in various industries 50
5.2.3.2 Growth opportunities in emerging countries 50
5.2.4 CHALLENGES 51
5.2.4.1 Limited commercialization and awareness of cold plasma 51
5.2.4.2 Limited presence of key players in developing countries 51
5.3 TECHNOLOGY ANALYSIS 52
5.3.1 KEY TECHNOLOGIES 52
5.3.1.1 Dielectric barrier discharge (DBD) 52
5.3.1.2 Atmospheric pressure plasma jet (APPJ) 52
5.3.2 COMPLEMENTARY TECHNOLOGIES 52
5.3.2.1 Ultraviolet (UV) 52
5.3.2.2 Electrostatic spraying 53
5.3.3 ADJACENT TECHNOLOGIES 53
5.3.3.1 Radiofrequency (RF) plasma 53
5.4 INDUSTRY TRENDS 53
5.4.1 INCREASING ADOPTION IN HEALTHCARE 53
5.4.2 FOOD SAFETY AND PRESERVATION 53
5.4.3 GROWTH IN TEXTILE AND MATERIAL PROCESSING 53
5.4.4 FOCUS ON SUSTAINABLE SOLUTIONS 53
5.5 SUPPLY CHAIN ANALYSIS 54
5.6 TRADE ANALYSIS 55
5.6.1 IMPORT DATA 55
5.6.2 EXPORT DATA 55
5.7 PORTER’S FIVE FORCES ANALYSIS 56
5.7.1 THREAT OF NEW ENTRANTS 57
5.7.2 THREAT OF SUBSTITUTES 57
5.7.3 BARGAINING POWER OF BUYERS 57
5.7.4 BARGAINING POWER OF SUPPLIERS 57
5.7.5 INTENSITY OF COMPETITIVE RIVALRY 57
5.8 REGULATORY ANALYSIS 57
5.8.1 REGULATORY LANDSCAPE 58
5.8.1.1 North America 58
5.8.1.1.1 US 58
5.8.1.1.2 Canada 58
5.8.1.2 Europe 58
5.8.1.3 Asia Pacific 59
5.8.1.3.1 India 59
5.8.1.3.2 China 59
5.8.1.3.3 Japan 59
5.8.1.4 Latin America 59
5.8.1.4.1 Brazil 59
5.8.1.4.2 Mexico 60
5.8.1.5 Middle East 60
5.8.1.6 Africa 60
5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 60
5.9 PATENT ANALYSIS 64
5.9.1 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 64
5.10 PRICING ANALYSIS 66
5.10.1 AVERAGE SELLING PRICE TREND OF COLD PLASMA SYSTEMS, BY KEY PLAYER 66
5.10.2 INDICATIVE PRICING ANALYSIS OF COLD PLASMA SYSTEMS, BY REGION 67
5.11 KEY CONFERENCES & EVENTS, 2024–2025 67
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 68
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 68
5.12.2 BUYING CRITERIA 69
5.13 ECOSYSTEM ANALYSIS 70
5.14 CASE STUDY ANALYSIS 72
5.15 REIMBURSEMENT ANALYSIS 73
5.16 UNMET NEEDS 73
5.17 VALUE CHAIN ANALYSIS 74
5.18 END-USER EXPECTATIONS 75
5.19 IMPACT AI ON COLD PLASMA MARKET 76
5.20 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 76
5.21 INVESTMENT & FUNDING SCENARIO 77
6 COLD PLASMA MARKET, BY INDUSTRY 78
6.1 INTRODUCTION 79
6.2 POLYMER & PLASTIC INDUSTRY 79
6.2.1 GROWING POPULARITY OF COLD PLASMA AS SURFACE MODIFICATION TECHNOLOGY TO BOOST MARKET GROWTH 79
6.3 TEXTILE INDUSTRY 81
6.3.1 ADVANTAGES OF COLD PLASMA TECHNOLOGY SUCH AS COST SAVINGS FOR TEXTILE PROCESSING TO DRIVE DEMAND 81
6.4 ELECTRONICS & SEMICONDUCTORS INDUSTRY 82
6.4.1 INCREASING USE OF COLD PLASMA IN SEMICONDUCTOR & ELECTRONICS MANUFACTURING TO FUEL GROWTH 82
6.5 FOOD & AGRICULTURE INDUSTRY 84
6.5.1 ABILITY OF COLD PLASMA TO ENHANCE SEED GERMINATION AND AGRICULTURAL PRODUCTIVITY TO FUEL GROWTH 84
6.6 MEDICAL INDUSTRY 85
6.6.1 RISING PREVALENCE OF CHRONIC WOUNDS AND SURGICAL-SITE INFECTIONS TO BOOST DEMAND 85
6.7 COSMETIC INDUSTRY 87
6.7.1 SHIFT TOWARD MINIMALLY INVASIVE COSMETIC PROCEDURES TO SUPPORT MARKET GROWTH 87
6.8 OTHER INDUSTRIES 88
7 COLD PLASMA MARKET, BY APPLICATION 90
7.1 INTRODUCTION 91
7.2 SURFACE TREATMENT & ACTIVATION 91
7.2.1 SURFACE TREATMENT APPLICATIONS TO DOMINATE POLYMER & PLASTIC INDUSTRY 91
7.3 COATING & THIN-FILM DEPOSITION 94
7.3.1 ABILITY OF PLASMA TO IMPROVE PERFORMANCE AND SAFETY OF ELECTRONICS & SEMICONDUCTORS TO DRIVE GROWTH 94
7.4 PRINTING 96
7.4.1 INCREASING USE OF COLD PLASMA AS EFFECTIVE ALTERNATIVE METHOD TO WET PROCESSING TO AID MARKET GROWTH 96
7.5 SURFACE CLEANING & DECONTAMINATION 98
7.5.1 SIGNIFICANT ADVANTAGES OF COLD PLASMA IN PACKAGING DECONTAMINATION TO SUPPORT GROWTH 98
7.6 WOUND HEALING 99
7.6.1 MAJOR APPLICATIONS OF COLD PLASMA IN MEDICAL INDUSTRY TO FAVOR MARKET 99
7.7 SURFACE ETCHING 101
7.7.1 SIGNIFICANT USE IN SEMICONDUCTOR INDUSTRY FOR PRINTING INTEGRATED CIRCUIT BOARDS TO BOOST MARKET 101
7.8 SURGICAL 103
7.8.1 WIDER APPLICATIONS OF COLD PLASMA IN SURGICAL TREATMENTS TO DRIVE MARKET 103
7.9 AESTHETIC PROCEDURES 105
7.9.1 GROWING NUMBER OF AESTHETIC PROCEDURES TO DRIVE MARKET GROWTH 105
7.10 OTHER APPLICATIONS 106
8 COLD PLASMA MARKET, BY REGIME 108
8.1 INTRODUCTION 109
8.2 ATMOSPHERIC COLD PLASMA 109
8.2.1 COST-EFFECTIVENESS OF ATMOSPHERIC COLD PLASMA TO DRIVE GROWTH 109
8.3 LOW-PRESSURE COLD PLASMA 111
8.3.1 ADVANTAGES SUCH AS BACTERICIDAL ACTIVITY AND MINIMAL SURFACE ABLATION TO DRIVE DEMAND 111
 
9 COLD PLASMA MARKET, BY REGION 113
9.1 INTRODUCTION 114
9.2 NORTH AMERICA 115
9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 118
9.2.2 US 119
9.2.2.1 US to dominate North American cold plasma market 119
9.2.3 CANADA 121
9.2.3.1 Rising cancer cases to drive market growth in Canada 121
9.3 EUROPE 123
9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 125
9.3.2 GERMANY 127
9.3.2.1 Germany to hold largest share of market in Europe 127
9.3.3 FRANCE 128
9.3.3.1 Growth in electronics & semiconductors industry to support market growth 128
9.3.4 UK 130
9.3.4.1 Rising funding for R&D and favorable investment scenario to aid growth 130
9.3.5 ITALY 132
9.3.5.1 Growing healthcare investment to support market growth 132
9.3.6 SPAIN 134
9.3.6.1 Rising prevalence of cancer to support market in Spain 134
9.3.7 REST OF EUROPE 136
9.4 ASIA PACIFIC 138
9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 141
9.4.2 JAPAN 143
9.4.2.1 Rising cancer incidence and growing geriatric population to fuel growth 143
9.4.3 CHINA 144
9.4.3.1 China to register highest growth in global cold plasma market 144
9.4.4 INDIA 146
9.4.4.1 Significant R&D spending in country to drive market 146
9.4.5 AUSTRALIA 148
9.4.5.1 Rising prevalence of cancer and government support to fuel market 148
9.4.6 SOUTH KOREA 150
9.4.6.1 Increasing benefits and awareness of cold plasma to boost market demand 150
9.4.7 REST OF ASIA PACIFIC 152
9.5 LATIN AMERICA 154
9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 156
9.5.2 BRAZIL 157
9.5.2.1 Brazil to dominate cold plasma market in Latin America 157
 
9.5.3 MEXICO 159
9.5.3.1 Improving healthcare to aid market growth 159
9.5.4 REST OF LATIN AMERICA 161
9.6 MIDDLE EAST & AFRICA 163
9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 165
9.6.2 GCC COUNTRIES 166
9.6.2.1 High healthcare spending capacity and industrial demands to propel growth 166
9.6.3 REST OF MIDDLE EAST & AFRICA 168
10 COMPETITIVE LANDSCAPE 171
10.1 OVERVIEW 171
10.2 KEY PLAYER STRATEGY/RIGHT TO WIN 171
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN COLD PLASMA MARKET 171
10.3 REVENUE ANALYSIS, 2019–2023 173
10.4 MARKET SHARE ANALYSIS, 2023 173
10.4.1 RANKING OF KEY MARKET PLAYERS 175
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 176
10.5.1 STARS 176
10.5.2 EMERGING LEADERS 176
10.5.3 PERVASIVE PLAYERS 176
10.5.4 PARTICIPANTS 176
10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 178
10.5.5.1 Company footprint 178
10.5.5.2 Industry footprint 179
10.5.5.3 Regime footprint 180
10.5.5.4 Region footprint 181
10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 182
10.6.1 PROGRESSIVE COMPANIES 182
10.6.2 RESPONSIVE COMPANIES 182
10.6.3 DYNAMIC COMPANIES 182
10.6.4 STARTING BLOCKS 182
10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 184
10.7 BRAND/PRODUCT COMPARISON 185
10.8 R&D ASSESSMENT OF KEY PLAYERS 186
10.9 COMPANY VALUATION & FINANCIAL METRICS 186
10.9.1 FINANCIAL METRICS 186
10.9.2 COMPANY VALUATION 187
10.10 COMPETITIVE SCENARIO 187
10.10.1 PRODUCT LAUNCHES & APPROVALS 187
10.10.2 EXPANSIONS 188
10.10.3 OTHER DEVELOPMENTS 189
11 COMPANY PROFILES 190
11.1 KEY PLAYERS 190
11.1.1 NORDSON CORPORATION 190
11.1.1.1 Business overview 190
11.1.1.2 Products offered 191
11.1.1.3 Recent developments 193
11.1.1.3.1 Product launches 193
11.1.1.4 MnM view 193
11.1.1.4.1 Right to win 193
11.1.1.4.2 Strategic choices 193
11.1.1.4.3 Weaknesses & competitive threats 193
11.1.2 ADTEC PLASMA TECHNOLOGY CO., LTD. 194
11.1.2.1 Business overview 194
11.1.2.2 Products offered 195
11.1.2.3 Recent developments 195
11.1.2.3.1 Product launches 195
11.1.2.3.2 Expansions 196
11.1.2.4 MnM view 196
11.1.2.4.1 Right to win 196
11.1.2.4.2 Strategic choices 196
11.1.2.4.3 Weaknesses & competitive threats 196
11.1.3 PLASMATREAT GMBH 197
11.1.3.1 Business overview 197
11.1.3.2 Products offered 197
11.1.3.3 Recent developments 198
11.1.3.3.1 Expansions 198
11.1.3.4 MnM view 198
11.1.3.4.1 Right to win 198
11.1.3.4.2 Strategic choices 198
11.1.3.4.3 Weaknesses & competitive threats 198
11.1.4 APYX MEDICAL 199
11.1.4.1 Business overview 199
11.1.4.2 Products offered 200
11.1.4.3 Recent developments 201
11.1.4.3.1 Product launches & approvals 201
11.1.4.4 MnM view 201
11.1.4.4.1 Right to win 201
11.1.4.4.2 Strategic choices 201
11.1.4.4.3 Weaknesses & competitive threats 202
 
11.1.5 RELYON PLASMA GMBH 203
11.1.5.1 Business overview 203
11.1.5.2 Products offered 203
11.1.5.3 Recent developments 204
11.1.5.3.1 Other developments 204
11.1.5.4 MnM view 204
11.1.5.4.1 Right to win 204
11.1.5.4.2 Strategic choices 204
11.1.5.4.3 Weaknesses & competitive threats 204
11.1.6 P2I LTD. 205
11.1.6.1 Business overview 205
11.1.6.2 Products offered 205
11.1.7 HENNIKER PLASMA 206
11.1.7.1 Business overview 206
11.1.7.2 Products offered 206
11.1.8 ENERCON INDUSTRIES CORPORATION 208
11.1.8.1 Business overview 208
11.1.8.2 Products offered 208
11.1.9 ACXYS PLASMA TECHNOLOGIES 209
11.1.9.1 Business overview 209
11.1.9.2 Products offered 209
11.1.10 TANTEC A/S 211
11.1.10.1 Business overview 211
11.1.10.2 Products offered 211
11.2 OTHER PLAYERS 213
11.2.1 EUROPLASMA NV 213
11.2.2 THIERRY CORP. 213
11.2.3 SURFX TECHNOLOGIES, LLC 214
11.2.4 SOFTAL CORONA & PLASMA GMBH 215
11.2.5 COATING PLASMA INNOVATION 216
11.2.6 FERRARINI & BENELLI SRL 216
11.2.7 NEOPLAS MED GMBH 217
11.2.8 TERRAPLASMA GMBH 218
11.2.9 MOLECULAR PLASMA GROUP 218
11.2.10 CINOGY TECHNOLOGIES GMBH 219
11.2.11 US MEDICAL INNOVATIONS 220
11.2.12 LEAFLIFE TECHNOLOGY 221
11.2.13 PLASMAWISE 222
11.2.14 PHASERTEK ENVIRONMENTAL LTD. 223
11.2.15 KEYLINK 223
 
12 APPENDIX 225
12.1 DISCUSSION GUIDE 225
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 229
12.3 CUSTOMIZATION OPTIONS 231
12.4 RELATED REPORTS 231
12.5 AUTHOR DETAILS 232